Clinical Trial Update: Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 study of AVE0005 (aflibercept) in platinum- and erlotinib-resistant locally advanced or metastatic non-small-cell lung cancer has completed. Results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AVE0005 (VEGF Trap) (ziv-aflibercept)

Snippet

Sponsor: Sanofi | Conditions: Pulmonary Diseases, Neoplasms, Lung | Phase 2 | Status: COMPLETED | Results posted: 2012-12-10